It may be significant clinically, because attenuating JNK activity could become a differentiation therapy-based approach for skin cancer in general and for tumors developed by familial cylindromatosis patients in particular.
← all excerpts
CYLD regulates keratinocyte differentiation and skin cancer progression in humans.
1
—
—